#101 Perianesthesia Challenges: Obesity, Weight Loss Medications, and Anesthesia – Risks, Side Effects, and More

Only available as part of a package

Overview
Contents (1)

With surging obesity rates, the FDA recently approved semaglutide and other GLP-1 agonists for weight loss. When combined with anesthesia, the risks of potential perianesthesia complications are increased. Be informed and learn if the benefits outweigh the risks.

1.25 contact hours